CVE-2007-6597

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in IPortalX before Build 033 allow remote attackers to inject arbitrary web script or HTML via the (1) KW and (2) SF parameters to forum/login_user.asp, and (3) the Date parameter to blogs.asp.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 2.02% Top 20%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/archive/1/485546/100/0/threaded mailing list
http://securityreason.com/securityalert/3504 third party advisory
http://osvdb.org/39861 vdb entry
http://osvdb.org/39860 vdb entry
http://www.securityfocus.com/bid/27044 vdb entry exploit
http://www.iportalx.net/forum/forum_posts.asp?TID=3465&PN=1 url repurposed
http://www.hackerscenter.com/Archive/view.asp?id=28137
http://secunia.com/advisories/28252 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/39249 vdb entry

Frequently Asked Questions

What is the severity of CVE-2007-6597?
CVE-2007-6597 has been scored as a medium severity vulnerability.
How to fix CVE-2007-6597?
To fix CVE-2007-6597, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2007-6597 being actively exploited in the wild?
It is possible that CVE-2007-6597 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.